AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Medicare Officials Want More Amyvid Trials

 Uncategorized  Comments Off on Medicare Officials Want More Amyvid Trials
Jul 092013
 

 

Amyvid

Medicare Officials Want More Amyvid Trials

Eli Lilly & Co. says it will push ahead with an imaging chemical designed to help screen for Alzheimer’s disease, despite a negative ruling by Medicare officials. The Centers for Medicare and Medicaid Services said last week it will not cover the chemical which highlights brain plaque in medical imaging scans.

FULL STORY

 

Eli Lilly & Co. says it will push ahead with a first-of-a-kind imaging chemical designed to help screen for Alzheimer’s disease, despite a negative ruling by Medicare officials.

The Centers for Medicare and Medicaid Services said last week it will not cover the chemical, called Amyvid, which highlights brain plaque in medical imaging scans. The government program provides health coverage to more than 47 million seniors, and is the largest payer for prescription drugs in the U.S.

http://www.dddmag.com/news/2013/07/medicare-officials-want-more-amyvid-trials?et_cid=3356136&et_rid=523035093&type=cta

Amyvid contains florbetapir F 18, a molecular imaging agent that binds to β-amyloid aggregates, and is intended for use with PET imaging of the brain. Chemically, florbetapir F 18 is described as (E)-4-(2-(6-(2-(2-(2[18F] fluoroethoxy)ethoxy)ethoxy)pyridine3-yl)vinyl)-N-methylbenzamine. The molecular weight is 359 and the structural formula is:

 

Amyvid (Florbetapir) Structural Formula Illustration

 

Amyvid is a sterile, non-pyrogenic radioactive diagnostic agent for intravenous injection. The clear, colorless solution is supplied ready to use and each milliliter contains 0.1 to 19 micrograms of florbetapir and 500 – 1900 MBq (13.5 – 51 mCi) florbetapir F 18 at EOS, with 4.5 mg sodium ascorbate USP, and 0.1 mL dehydrated alcohol USP in 0.9% sodium chloride injection USP. The pH of the solution is between 5.5 and 7.5.

Physical Characteristics

Amyvid is radiolabeled with [18F] fluorine (F 18) that decays by positron (β+) emission to O 18 and has a half-life of 109.77 minutes. The principal photons useful for diagnostic imaging are the coincident pair of 511 keV gamma photons, resulting from the interaction of the emitted positron with an electron (Table 3).

Table 3: Principal Radiation Produced from Decay of Fluorine 18

Radiation Energy Level (keV) Abundance (%)
Positron 249.8 96.9
Gamma 511 193.5

 

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: